Insider Trading & Ownership - Opaleye Management Inc.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Opaleye Management Inc.
Goto Prev, 0, 1, 2, 3
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-10-08
Sale
2021-10-13
07:57 am
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
165,100 $5.0313 $830,670 117,100
(Indirect)
View
2021-08-19
Purchase
2021-08-23
5:59 pm
HARROW HEALTH INC. HROW Opaleye Management Inc.
10% Owner
52,500 $8.445 $443,363 150,000
(Indirect)
View
2021-08-17
Purchase
2021-08-19
7:10 pm
HARROW HEALTH INC. HROW Opaleye Management Inc.
10% Owner
72,500 $8.6165 $624,697 147,500
(Indirect)
View
2021-08-04
Sale
2021-08-06
9:53 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
604,500 $5.8283 $3,523,187 117,100
(Indirect)
View
2021-07-19
Purchase
2021-07-22
09:19 am
HARROW HEALTH INC. HROW Opaleye Management Inc.
10% Owner
20,000 $7.3145 $146,290 145,000
(Indirect)
View
2021-06-17
Purchase
2021-06-22
11:44 am
HARROW HEALTH INC. HROW Opaleye Management Inc.
10% Owner
74,584 $8.3448 $622,389 140,000
(Indirect)
View
2021-06-15
Sale(A)
2021-06-21
06:05 am
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
105,000 $8.07 $847,350 141,600
(Indirect)
View
2021-06-15
Sale
2021-06-17
4:39 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
105,000 $8.07 $847,350 141,600
(Indirect)
View
2021-05-25
Sale
2021-05-27
7:34 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
242,300 $8.5205 $2,064,511 145,600
(Indirect)
View
2020-12-22
Purchase
2020-12-28
09:53 am
Tracon Pharmaceuticals Inc. TCON Opaleye Management Inc.
10% Owner
496,277 $8.06 $3,999,993 5,766,877
(Indirect)
View
2020-12-18
Purchase
2020-12-22
6:09 pm
HARROW HEALTH INC. HROW Opaleye Management Inc.
10% Owner
106,416 $5.2575 $559,482 136,016
(Indirect)
View
2020-10-21
Purchase
2020-10-23
9:30 pm
Tracon Pharmaceuticals Inc. TCON Opaleye Management Inc.
10% Owner
8,656 $4.3969 $38,060 5,045,600
(Indirect)
View
2020-10-16
Purchase
2020-10-16
9:30 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
400,000 $7 $2,800,000 155,000
(Indirect)
View
2020-09-30
Purchase
2020-10-02
06:05 am
Protara Therapeutics Inc. TARA Opaleye Management Inc.
10% Owner
50,000 $16 $800,000 2,558,472
(Indirect)
View
2020-09-23
Purchase
2020-09-25
9:30 pm
Tracon Pharmaceuticals Inc. TCON Opaleye Management Inc.
10% Owner
78,734 $4.726 $372,095 5,033,944
(Indirect)
View
2020-09-24
Purchase
2020-09-25
5:15 pm
Protara Therapeutics Inc. TARA Opaleye Management Inc.
10% Owner
300,000 $16.87 $5,061,000 2,408,472
(Indirect)
View
2020-09-04
Purchase
2020-09-09
6:15 pm
Tracon Pharmaceuticals Inc. TCON Opaleye Management Inc.
10% Owner
56,558 $3.3753 $190,902 4,957,944
(Indirect)
View
2020-09-01
Purchase
2020-09-03
5:15 pm
Tracon Pharmaceuticals Inc. TCON Opaleye Management Inc.
10% Owner
159,800 $2.2768 $363,825 4,904,452
(Indirect)
View
2020-08-27
Purchase
2020-08-31
9:36 pm
Tracon Pharmaceuticals Inc. TCON Opaleye Management Inc.
10% Owner
545,504 $1.7422 $950,378 4,750,852
(Indirect)
View
2020-07-10
Purchase
2020-07-14
9:45 pm
HARROW HEALTH INC. HROW Opaleye Management Inc.
10% Owner
112,700 $4.9701 $560,133 131,900
(Indirect)
View
2020-07-07
Purchase
2020-07-09
9:30 pm
HARROW HEALTH INC. HROW Opaleye Management Inc.
10% Owner
136,300 $5.0162 $683,704 130,000
(Indirect)
View
2020-06-19
Purchase
2020-06-23
9:45 pm
HARROW HEALTH INC. HROW Opaleye Management Inc.
10% Owner
35,000 $5.5829 $195,402 2,710,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2020-08-31
9:33 pm
N/A
N/A
Tracon Pharmaceuticals Inc. TCON Opaleye Management Inc.
10% Owner
0 $0 3,062,355
(Indirect)
View
(A) Indicate amendment filing.
Goto Prev, 0, 1, 2, 3